Nutritional Approaches to Combat Oxidative Stress in Alzheimer's
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Potential Applications of Curcumin and Curcumin Nanoparticles: from Traditional Therapeutics to Modern Nanomedicine
Nanotechnol Rev 2015; 4(2): 161–172 Review Mahendra Rai*, Raksha Pandit, Swapnil Gaikwad, Alka Yadav and Aniket Gade Potential applications of curcumin and curcumin nanoparticles: from traditional therapeutics to modern nanomedicine Abstract: Curcumin (diferuloylmethane) is one of the regions throughout the world and widely cultivated in potent, nontoxic, and major bioactive components pre- Asian countries, mostly in India and China [2, 3]. sent in turmeric. The major drawbacks of curcumin are Curcumin was isolated for the first time in 1815, while low absorption and poor bioavailability. The present its chemical structure was determined in 1973 by Rough- review highlights on the methods for the fabrication of ley and Whiting (Figure 1). The melting point of curcumin curcumin nanoparticles and their applications in treat- is 176–177°C, and it forms red to brown-colored salts when ment of cancer and wound infections. Curcumin nano- treated with alkalis [4]. Commercial curcumin possess particles possess remarkable antibacterial, antiviral, and approximately 77% diferuloylmethane, 17% demethoxy- antiprotozoan activity. Hence, curcumin nanoparticle- curcumin (Figure 2), and 6% bisdemethoxycurcumin [5] loaded nano-gel, microemulsion, and nano-cream can be (Figure 3). Curcumin is a natural compound, which is used for drug delivery. hydrophobic in nature. It consists of two polyphenolic rings, which are substituted by methoxy ether at the Keywords: antimicrobial activity; curcumin; curcumin ortho position, and tautomerization of curcumin arises nanoparticles. in a pH-dependent condition [6]; in neutral and acidic conditions, curcumin possesses a bis-keto form [1,7-bis (4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione]. DOI 10.1515/ntrev-2015-0001 Received January 2, 2015; accepted February 4, 2015; previously pub- Curcumin functions as an antioxidant, anti-inflamma- lished online March 19, 2015 tory, and anti-atherosclerotic. -
Antioxidant Efficacy of Curcuminoids from Turmeric ( Curcuma Longa L
Downloaded from British Journal of Nutrition (2009), 102, 1629–1634 doi:10.1017/S0007114509990869 q The Authors 2009 https://www.cambridge.org/core Antioxidant efficacy of curcuminoids from turmeric (Curcuma longa L.) powder in broiler chickens fed diets containing aflatoxin B1 Nisarani K. S. Gowda1*, David R. Ledoux2, Goerge E. Rottinghaus2, Alex J. Bermudez2 and Yin C. Chen2 . IP address: 1National Institute of Animal Nutrition and Physiology, Bangalore 560030, India 2Fusarium/Poultry Research Laboratory, University of Missouri, Columbia, MO 65211, USA 170.106.35.76 (Received 6 November 2008 – Revised 21 May 2009 – Accepted 28 May 2009 – First published online 17 August 2009) , on A 3-week-feeding study (1–21 d post-hatch) was conducted to evaluate the efficacy of total curcuminoids (TCMN), as an antioxidant, to amelio- 29 Sep 2021 at 12:56:31 rate the adverse effects of aflatoxin B1 (AFB1) in broiler chickens. Turmeric powder (Curcuma longa L.) that contained 2·55 % TCMN was used as a source of TCMN. Six cage replicates of five chicks each were assigned to each of six dietary treatments, which included: basal diet; basal diet supplemented with 444 mg/kg TCMN; basal diet supplemented with 1·0 mg/kg AFB1; basal diet supplemented with 74 mg/kg TCMN and 1·0 mg/kg AFB1; basal diet supplemented with 222 mg/kg TCMN and 1·0 mg/kg AFB1; basal diet supplemented with 444 mg/kg TCMN and 1·0 mg/kg AFB1. The addition of 74 and 222 mg/kg TCMN to the AFB1 diet significantly (P,0·05) improved weight gain and feed efficiency. -
Hepcidin Therapeutics
pharmaceuticals Review Hepcidin Therapeutics Angeliki Katsarou and Kostas Pantopoulos * Lady Davis Institute for Medical Research, Jewish General Hospital, Department of Medicine, McGill University, Montreal, QC H3T 1E2, Canada; [email protected] * Correspondence: [email protected]; Tel.: +1-(514)-340-8260 (ext. 25293) Received: 3 November 2018; Accepted: 19 November 2018; Published: 21 November 2018 Abstract: Hepcidin is a key hormonal regulator of systemic iron homeostasis and its expression is induced by iron or inflammatory stimuli. Genetic defects in iron signaling to hepcidin lead to “hepcidinopathies” ranging from hereditary hemochromatosis to iron-refractory iron deficiency anemia, which are disorders caused by hepcidin deficiency or excess, respectively. Moreover, dysregulation of hepcidin is a pathogenic cofactor in iron-loading anemias with ineffective erythropoiesis and in anemia of inflammation. Experiments with preclinical animal models provided evidence that restoration of appropriate hepcidin levels can be used for the treatment of these conditions. This fueled the rapidly growing field of hepcidin therapeutics. Several hepcidin agonists and antagonists, as well as inducers and inhibitors of hepcidin expression have been identified to date. Some of them were further developed and are currently being evaluated in clinical trials. This review summarizes the state of the art. Keywords: iron metabolism; hepcidin; ferroportin; hemochromatosis; anemia 1. Systemic Iron Homeostasis Iron is an essential constituent of cells and organisms and participates in vital biochemical activities, such as DNA synthesis, oxygen transfer, and energy metabolism. The biological functions of iron are based on its capacity to interact with proteins and on its propensity to switch between the ferrous (Fe2+) and ferric (Fe3+) oxidation states. -
Impact of High Pressure on the Infusion of Curcuminoids in Pineapple Slices
George JM and Rastogi NK, J Food Sci Nutr 2017, 3: 027 DOI: 10.24966/FSN-1076/100027 HSOA Journal of Food Science and Nutrition Research Article by many research workers. However, it is relatively a slow and time Impact of High Pressure on the consuming process. Hence, a few techniques have been acknowledged in order to enhance the rate of osmotically induced mass transfer that Infusion of Curcuminoids in include partial vacuum [10,11], pulsed vacuum [12], high pressure [13-15], high intensity pulsed electric field [16,17], ohmic heating Pineapple Slices [18,19] or ultrasound [20-23]. Application of high pressure treatment Jincy M George1,2 and Navin K Rastogi1,2* accelerated the diffusion of bioactive components into the solid food 1ACSIR, Central Food Technological Research Institute, Mysore, India due to cell membranes permeabilisation resulting in decline in the re- sistance to infusion [24,25]. The application of high pressure pretreat- 2 Department of Food Engineering, Central Food Technological Research ment was described to increase the water and solute diffusion during Institute, Mysore, India osmotic dehydration of pineapples, potato, glutinous rice and turkey breast [26-29]. Sila et al., [30] demonstrated that combined effect of high pressure treatment and CaCl2 treatment improved the texture of carrots during thermal processing. High pressure-assisted infusion of pectin methyl esterase and calcium chloride in strawberry was shown to improve the firmness [13,31]. Mahadevan et al., [32] indicated that high pressure pretreatment increased infusion of quercetin by 3 times into cranberries as compared to untreated ones. Incorporation of synthetic antioxidants like Butylated Hydroxy- anisole (BHA) and Butylated Hydroxy Toluene (BHT) are restricted Abstract by legislative laws and regulations due to carcinogenic effects [33]. -
|||||||||||||III US005202354A United States Patent (19) (11) Patent Number: 5,202,354 Matsuoka Et Al
|||||||||||||III US005202354A United States Patent (19) (11) Patent Number: 5,202,354 Matsuoka et al. 45) Date of Patent: Apr. 13, 1993 (54) COMPOSITION AND METHOD FOR 4,528,295 7/1985 Tabakoff .......... ... 514/562 X REDUCING ACETALDEHYDE TOXCTY 4,593,020 6/1986 Guinot ................................ 514/811 (75) Inventors: Masayoshi Matsuoka, Habikino; Go OTHER PUBLICATIONS Kito, Yao, both of Japan Sprince et al., Agents and Actions, vol. 5/2 (1975), pp. 73) Assignee: Takeda Chemical Industries, Ltd., 164-173. Osaka, Japan Primary Examiner-Arthur C. Prescott (21) Appl. No.: 839,265 Attorney, Agent, or Firn-Wenderoth, Lind & Ponack 22) Filed: Feb. 21, 1992 (57) ABSTRACT A novel composition and method are disclosed for re Related U.S. Application Data ducing acetaldehyde toxicity, especially for preventing (63) Continuation of Ser. No. 13,443, Feb. 10, 1987, aban and relieving hangover symptoms in humans. The com doned. position comprises (a) a compound of the formula: (30) Foreign Application Priority Data Feb. 18, 1986 JP Japan .................................. 61-34494 51) Int: C.5 ..................... A01N 37/00; A01N 43/08 52 U.S. C. ................................. ... 514/562; 514/474; 514/81 wherein R is hydrogen or an acyl group; R' is thiol or 58) Field of Search ................ 514/557, 562, 474,811 sulfonic group; and n is an integer of 1 or 2, (b) ascorbic (56) References Cited acid or a salt thereof and (c) a disulfide type thiamine derivative or a salt thereof. The composition is orally U.S. PATENT DOCUMENTS administered, preferably in the form of tablets. 2,283,817 5/1942 Martin et al. -
Curcumin and Resveratrol in the Management of Cognitive Disorders: What Is the Clinical Evidence?
Review Curcumin and Resveratrol in the Management of Cognitive Disorders: What is the Clinical Evidence? Gabriela Mazzanti * and Silvia Di Giacomo Department of Physiology and Pharmacology, Sapienza - University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy. * Correspondence: [email protected]; Tel.: +39-064-991-2903 Academic Editor: Luigia Trabace Received: 26 July 2016; Accepted: 12 September 2016; Published: 17 September 2016 Abstract: A growing body of in vitro and in vivo evidences shows a possible role of polyphenols in counteracting neurodegeneration: curcumin and resveratrol are attractive substances in this regard. In fact, epidemiological studies highlight a neuroprotective effect of turmeric (rhizome of Curcuma longa L.), the main source of curcumin. Moreover, the consumption of red wine, the main source of resveratrol, has been related to a lower risk of developing dementia. In this review, we analyzed the published clinical trials investigating curcumin and resveratrol in the prevention or treatment of cognitive disorders. The ongoing studies were also described, in order to give an overview of the current search on this topic. The results of published trials (five for curcumin, six for resveratrol) are disappointing and do not allow to draw conclusions about the therapeutic or neuroprotective potential of curcumin and resveratrol. These compounds, being capable of interfering with several processes implicated in the early stages of dementia, could be useful in preventing or in slowing down the pathology. To this aim, an early diagnosis using peripheral biomarkers becomes necessary. Furthermore, the potential preventive activity of curcumin and resveratrol should be evaluated in long-term exposure clinical trials, using preparations with high bioavailability and that are well standardized. -
Review Article Polyphenols As Modulator of Oxidative Stress in Cancer Disease: New Therapeutic Strategies
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Crossref Hindawi Publishing Corporation Oxidative Medicine and Cellular Longevity Volume 2016, Article ID 6475624, 17 pages http://dx.doi.org/10.1155/2016/6475624 Review Article Polyphenols as Modulator of Oxidative Stress in Cancer Disease: New Therapeutic Strategies Anna Maria Mileo and Stefania Miccadei Regina Elena National Cancer Institute, 00144 Rome, Italy Correspondence should be addressed to Stefania Miccadei; [email protected] Received 22 May 2015; Accepted 21 July 2015 Academic Editor: Amit Tyagi Copyright © 2016 A. M. Mileo and S. Miccadei. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Cancer onset and progression have been linked to oxidative stress by increasing DNA mutations or inducing DNA damage, genome instability, and cell proliferation and therefore antioxidant agents could interfere with carcinogenesis. It is well known that conventional radio-/chemotherapies influence tumour outcome through ROS modulation. Since these antitumour treatments have important side effects, the challenge is to develop new anticancer therapeutic strategies more effective and less toxic for patients. To this purpose, many natural polyphenols have emerged as very promising anticancer bioactive compounds. Beside their well-known antioxidant activities, several polyphenols target epigenetic processes involved in cancer development through the modulation of oxidative stress. An alternative strategy to the cytotoxic treatment is an approach leading to cytostasis through the induction of therapy-induced senescence. Many anticancer polyphenols cause cellular growth arrest through the induction of a ROS-dependent premature senescence and are considered promising antitumour therapeutic tools. -
Genome Sequencing of Turmeric Provides Evolutionary Insights Into Its Medicinal Properties
bioRxiv preprint doi: https://doi.org/10.1101/2020.09.07.286245; this version posted September 9, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Title: Genome sequencing of turmeric provides evolutionary insights into its medicinal properties 2 Authors: Abhisek Chakraborty, Shruti Mahajan, Shubham K. Jaiswal, Vineet K. Sharma* 3 4 Affiliation: 5 MetaBioSys Group, Department of Biological Sciences, Indian Institute of Science Education and 6 Research Bhopal 7 8 *Corresponding Author email: 9 Vineet K. Sharma - [email protected] 10 11 E-mail addresses of authors: 12 Abhisek Chakraborty - [email protected], Shruti Mahajan - [email protected], Shubham K. 13 Jaiswal - [email protected], Vineet K. Sharma - [email protected] bioRxiv preprint doi: https://doi.org/10.1101/2020.09.07.286245; this version posted September 9, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 14 ABSTRACT 15 Curcuma longa, or turmeric, is traditionally known for its immense medicinal properties and has 16 diverse therapeutic applications. However, the absence of a reference genome sequence is a limiting 17 factor in understanding the genomic basis of the origin of its medicinal properties. In this study, we 18 present the draft genome sequence of Curcuma longa, the first species sequenced from 19 Zingiberaceae plant family, constructed using 10x Genomics linked reads. For comprehensive gene 20 set prediction and for insights into its gene expression, the transcriptome sequencing of leaf tissue 21 was also performed. -
Marrakesh Agreement Establishing the World Trade Organization
No. 31874 Multilateral Marrakesh Agreement establishing the World Trade Organ ization (with final act, annexes and protocol). Concluded at Marrakesh on 15 April 1994 Authentic texts: English, French and Spanish. Registered by the Director-General of the World Trade Organization, acting on behalf of the Parties, on 1 June 1995. Multilat ral Accord de Marrakech instituant l©Organisation mondiale du commerce (avec acte final, annexes et protocole). Conclu Marrakech le 15 avril 1994 Textes authentiques : anglais, français et espagnol. Enregistré par le Directeur général de l'Organisation mondiale du com merce, agissant au nom des Parties, le 1er juin 1995. Vol. 1867, 1-31874 4_________United Nations — Treaty Series • Nations Unies — Recueil des Traités 1995 Table of contents Table des matières Indice [Volume 1867] FINAL ACT EMBODYING THE RESULTS OF THE URUGUAY ROUND OF MULTILATERAL TRADE NEGOTIATIONS ACTE FINAL REPRENANT LES RESULTATS DES NEGOCIATIONS COMMERCIALES MULTILATERALES DU CYCLE D©URUGUAY ACTA FINAL EN QUE SE INCORPOR N LOS RESULTADOS DE LA RONDA URUGUAY DE NEGOCIACIONES COMERCIALES MULTILATERALES SIGNATURES - SIGNATURES - FIRMAS MINISTERIAL DECISIONS, DECLARATIONS AND UNDERSTANDING DECISIONS, DECLARATIONS ET MEMORANDUM D©ACCORD MINISTERIELS DECISIONES, DECLARACIONES Y ENTEND MIENTO MINISTERIALES MARRAKESH AGREEMENT ESTABLISHING THE WORLD TRADE ORGANIZATION ACCORD DE MARRAKECH INSTITUANT L©ORGANISATION MONDIALE DU COMMERCE ACUERDO DE MARRAKECH POR EL QUE SE ESTABLECE LA ORGANIZACI N MUND1AL DEL COMERCIO ANNEX 1 ANNEXE 1 ANEXO 1 ANNEX -
Product Infomation | Nabolin EB
本製品は日本国法に基づき製造販売されたものです。 製品および文書は日本国外の法規に準じているわけではありません。 本文書は、日本語の製品情報を翻訳した文書です。使用前に必ずお読みください。 また、必要な時に読めるように大切に保管してください。 This product has been manufactured and sold based on Japanese law. Neither the product nor this informational leaflet will necessarily conform to the laws of countries outside of Japan. This leaflet contains a translation of product information from Japanese. You should read this written explanation before using the product. Store this informational leaflet safely so that it can be read when necessary. Discovering everything from prevention to cure Category-3 OTC drug Relief of stiff shoulder, lumbago, and numbness in the limbs Nabolin EB Stiffness of the shoulders and lumbago occur due to excessive loads on the shoulder or low back. If you stay in the same posture or try to maintain a difficult posture, the muscles in your shoulders or low back may harden, damaging the peripheral nerves, and causing stiffness or pain. The main ingredient of ナボリン EB 錠 is activated vitamin B12 (mecobalamin), which repairs peripheral nerve damage and relieves stiff shoulder and lumbago. Mecobalamin is one of the four types of vitamin B12, an activated type of vitamin B12 that is easy for the body to Recommended retail price Package use and acts directly on peripheral nerves. ナボリン EB (tax included) 錠 also contain vitamins B1, B6, and E, which have an 45 tablets ¥2,592 effect on stiff shoulders and lumbago that appear due to muscle fatigue or poor circulation. 120 tablets ¥6,264 Related website ナボリン Club (in Japanese) Indications Relief of the following symptoms: stiffness in the shoulder and neck, lumbago, neuralgia, and numbness in the limbs (A physician or pharmacist should be consulted if there is no improvement after about 1 month of administration) Dosage and Administration Take the following doses with cold or hot water after a meal. -
Polyphenols of the Mediterranean Diet and Their Metabolites in the Prevention of Colorectal Cancer
molecules Review Polyphenols of the Mediterranean Diet and Their Metabolites in the Prevention of Colorectal Cancer Aline Yammine 1,†, Amira Namsi 1,† , Dominique Vervandier-Fasseur 2 , John J. Mackrill 3 ,Gérard Lizard 1,‡ and Norbert Latruffe 1,* 1 Team Bio-PeroxIL, “Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism” (EA7270), University of Bourgogne Franche-Comté, Inserm, 21000 Dijon, France; [email protected] (A.Y.); [email protected] (A.N.); [email protected] (G.L.) 2 Team OCS, Institute of Molecular Chemistry of University of Burgundy (ICMUB UMR CNRS 6302), University of Bourgogne Franche-Comté, 21000 Dijon, France; [email protected] 3 Department of Physiology, University College Cork, BioScience Institute, College Road, T12 YT20 Cork, Ireland; [email protected] * Correspondence: [email protected]; Tel.:+33-380-396-237; Fax: +33-380-396-250 † These authors contributed equally to this work. ‡ Inserm Researcher; Researcher attached to the international network of the UNESCO Chair ‘Culture and tradition of wine’. Abstract: The Mediterranean diet is a central element of a healthy lifestyle, where polyphenols play a key role due to their anti-oxidant properties, and for some of them, as nutripharmacological compounds capable of preventing a number of diseases, including cancer. Due to the high prevalence of intestinal cancer (ranking second in causing morbidity and mortality), this review is focused on the beneficial effects of selected dietary phytophenols, largely present in Mediterranean cooking: apigenin, curcumin, epigallocatechin gallate, quercetin-rutine, and resveratrol. The role of the Citation: Yammine, A.; Namsi, A.; Vervandier-Fasseur, D.; Mackrill, J.J.; Mediterranean diet in the prevention of colorectal cancer and future perspectives are discussed in Lizard, G.; Latruffe, N. -
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
20558 Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DEPARMENT OF THE TREASURY Services, U.S. Customs Service, 1301 TABLE 1.ÐPHARMACEUTICAL APPEN- Constitution Avenue NW, Washington, DIX TO THE HTSUSÐContinued Customs Service D.C. 20229 at (202) 927±1060. CAS No. Pharmaceutical [T.D. 95±33] Dated: April 14, 1995. 52±78±8 ..................... NORETHANDROLONE. A. W. Tennant, 52±86±8 ..................... HALOPERIDOL. Pharmaceutical Tables 1 and 3 of the Director, Office of Laboratories and Scientific 52±88±0 ..................... ATROPINE METHONITRATE. HTSUS 52±90±4 ..................... CYSTEINE. Services. 53±03±2 ..................... PREDNISONE. 53±06±5 ..................... CORTISONE. AGENCY: Customs Service, Department TABLE 1.ÐPHARMACEUTICAL 53±10±1 ..................... HYDROXYDIONE SODIUM SUCCI- of the Treasury. NATE. APPENDIX TO THE HTSUS 53±16±7 ..................... ESTRONE. ACTION: Listing of the products found in 53±18±9 ..................... BIETASERPINE. Table 1 and Table 3 of the CAS No. Pharmaceutical 53±19±0 ..................... MITOTANE. 53±31±6 ..................... MEDIBAZINE. Pharmaceutical Appendix to the N/A ............................. ACTAGARDIN. 53±33±8 ..................... PARAMETHASONE. Harmonized Tariff Schedule of the N/A ............................. ARDACIN. 53±34±9 ..................... FLUPREDNISOLONE. N/A ............................. BICIROMAB. 53±39±4 ..................... OXANDROLONE. United States of America in Chemical N/A ............................. CELUCLORAL. 53±43±0